Quick Answer
Vor Biopharma Inc. reported Total Assets of $464.13 million for fiscal year 2025.
Vor Biopharma Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $464.13M | +224.8% |
| 2024 | $142.89M | -27.9% |
| 2023 | $198.13M | -33.8% |
| 2022 | $299.37M | +23.4% |
| 2021 | $242.59M | +219.6% |
| 2020 | $75.91M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $176.24M | +51.9% | -14.2% |
| June 30, 2025 | $205.37M | +45.0% | +87.9% |
| March 31, 2025 | $109.31M | -34.6% | -23.5% |
| December 31, 2024 | $142.89M | -27.9% | +23.2% |
| September 30, 2024 | $115.99M | -48.0% | -18.1% |
| June 30, 2024 | $141.59M | -43.6% | -15.2% |
| March 31, 2024 | $167.03M | -39.8% | -15.7% |
| December 31, 2023 | $198.13M | -33.8% | -11.2% |
- Vor Biopharma Inc. showed an increase of +224.8% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Vor Biopharma Inc.’s total assets has grown by 511.4% (from $75.91 million to $464.13 million).
- The most recent figure is from Vor Biopharma Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: